156 related articles for article (PubMed ID: 21087111)
1. Vaccine presentation in the USA: economics of prefilled syringes versus multidose vials for influenza vaccination.
Pereira CC; Bishai D
Expert Rev Vaccines; 2010 Nov; 9(11):1343-9. PubMed ID: 21087111
[TBL] [Abstract][Full Text] [Related]
2. Estimating medical practice expenses from administering adult influenza vaccinations.
Coleman MS; Fontanesi J; Meltzer MI; Shefer A; Fishbein DB; Bennett NM; Stryker D
Vaccine; 2005 Jan; 23(7):915-23. PubMed ID: 15603893
[TBL] [Abstract][Full Text] [Related]
3. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
4. Improving influenza vaccination rates in the workplace: a randomized trial.
Nowalk MP; Lin CJ; Toback SL; Rousculp MD; Eby C; Raymund M; Zimmerman RK
Am J Prev Med; 2010 Mar; 38(3):237-46. PubMed ID: 20036102
[TBL] [Abstract][Full Text] [Related]
5. [Cost of tetanus toxoid injection using a jet-injector (Imule) in collective immunization in Senegal: comparison with injection using a syringe and resterilizable needle].
Schlumberger M; Châtelet IP; Lafarge H; Genêt A; Gaye AB; Monnereau A; Sanou C; Diawara L; Gueye Y; Lang J
Sante; 1999; 9(5):319-26. PubMed ID: 10657777
[TBL] [Abstract][Full Text] [Related]
6. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.
Myers ER; Misurski DA; Swamy GK
Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S128-40. PubMed ID: 21640230
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
[TBL] [Abstract][Full Text] [Related]
8. Influenza vaccines provide diminished protection but are cost-saving in older adults.
Deans GD; Stiver HG; McElhaney JE
J Intern Med; 2010 Feb; 267(2):220-7. PubMed ID: 20175868
[TBL] [Abstract][Full Text] [Related]
9. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
10. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
Iskander J; Broder K
Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
[TBL] [Abstract][Full Text] [Related]
11. Immunisation and multi-dose vials.
Gosbell IB; Gottlieb T; Kesson AM; Post JJ; Dwyer DE
Vaccine; 2010 Sep; 28(40):6556-61. PubMed ID: 20678588
[TBL] [Abstract][Full Text] [Related]
12. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device.
Sutanto A; Suarnawa IM; Nelson CM; Stewart T; Soewarso TI
Bull World Health Organ; 1999; 77(2):119-26. PubMed ID: 10083709
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of influenza immunization for inner-city children aged 6 to 23 months.
Zimmerman RK; Hoberman A; Nowalk MP; Lin CJ; Greenberg DP; Weinberg ST; Bemm CW; Block B
Am J Prev Med; 2004 Dec; 27(5):397-403. PubMed ID: 15556740
[TBL] [Abstract][Full Text] [Related]
15. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries.
Drain PK; Nelson CM; Lloyd JS
Bull World Health Organ; 2003; 81(10):726-31. PubMed ID: 14758432
[TBL] [Abstract][Full Text] [Related]
16. A personnel time-motion study of intranasal influenza vaccination in healthy children.
Washington ML; Humiston SG; Fauerbach PB; Glezen WP; Black S; Shinefield H; Pulley J
Vaccine; 2005 Sep; 23(40):4879-85. PubMed ID: 16005551
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of influenza vaccination in working-age cancer patients.
Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
[TBL] [Abstract][Full Text] [Related]
19. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
20. Vaccination, consent and multidose vials.
Diamond MR; O'Brien-Malone A
Med J Aust; 2011 Apr; 194(8):414-6. PubMed ID: 21495943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
